Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASTRO 2022 | Future developments in cervical cancer treatment

Jyoti Mayadev • 21 Oct 2022
ASTRO 2022
Cervical Cancer Gynecological Cancer
CALLA

Jyoti Mayadev, MD, University of California San Diego Medical Center, San Diego, CA, highlights the need for improved treatments for high-risk cervical cancer patients, including developments in immunotherapy and chemoradiotherapy. This interview took place at the American Society for Radiation Oncology (ASTRO) 2022 Congress in San Antonio, Tx.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Disclosures

Consulting with Astra Zeneca

More from Jyoti Mayadev

1:42
Unmet needs in radiotherapy for cervical cancer
Jyoti Mayadev • 21 Oct 2022
5:20
CALLA: Phase III study of durvalumab and chemoradiotherapy for cervical cancer
Jyoti Mayadev • 21 Oct 2022

Related Videos

0:39
Early diagnosis of ovarian cancer with Pap smears
Sergio Marchini • 8 Apr 2024
0:46
FRa expression and sequencing ADCs in endometrial cancer
Rebecca Porter • 8 Apr 2024
4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:11
Clonal hematopoiesis mutations in ovarian carcinomas
Rebecca Porter • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals